Dashboard
Manage Tickers

CASI


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

casi-pharma-says-position-of-president-of-the-company-was-removed-effective-from-september-10-2024
CASI Pharma Says Position Of President Of ...
09/12/2024 11:49:13

Instead, a Senior Vice President in charge of coordination and management of synergistic projects between China and US and mana...

casi-pharmaceuticals-q2-eps-052-beats-063-estimate-sales-398m-miss-443m-estimate
CASI Pharmaceuticals Q2 EPS $(0.52) Beats ...
08/16/2024 12:02:06

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of ...

casi-pharma-taps-athenexs-daniel-lang-md-as-cfo
CASI Pharma Taps Athenex's Daniel Lang, MD...
07/08/2024 11:33:54

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a Cayman incorporated biopharmaceutical company focused on developing and commerciali...

Core News & Articles
Market-Moving News for June 27th
06/27/2024 12:37:40

CASI: 92% | CASI Pharmaceuticals Announced Plan To Submit CID-103 IND Application; Also Announces Receipt Of A Non-binding Prop...

casi-pharmaceuticals-announced-plan-to-submit-cid-103-ind-application-also-announces-receipt-of-a-non-binding-proposal-to-acquire-its-china-business-for-aggregate-purchase-price-of-40m
CASI Pharmaceuticals Announced Plan To Sub...
06/26/2024 20:16:48

casi-pharmaceuticals-announces-a-15m-private-placement-financing-by-venrock-healthcare-capital-partners-foresite-capital-panacea-venture-and-dr-wei-wu-he
CASI Pharmaceuticals Announces A $15M Priv...
06/26/2024 20:12:57

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
06/21/2024 12:08:00

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
06/20/2024 16:32:10

hc-wainwright--co-maintains-buy-on-casi-pharmaceuticals-lowers-price-target-to-6
HC Wainwright & Co. Maintains Buy on CASI ...
05/15/2024 15:46:43

HC Wainwright & Co. analyst Sean Lee maintains CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and lowers the price target...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/15/2024 12:06:56

casi-pharmaceuticals-gets-fda-clearance-on-the-ind-application-for-cid-103-in-immune-thrombocytopenia
CASI Pharmaceuticals Gets FDA Clearance On...
05/15/2024 12:04:58

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development and commercialization of ...

casi-pharmaceuticals-q1-eps-071-misses-005-estimate-sales-341m-miss-1200m-estimate
CASI Pharmaceuticals Q1 EPS $(0.71) Misses...
05/14/2024 12:23:53

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate o...

casi-pharmaceuticals-discloses-material-development-relating-to-its-dispute-with-juventas
CASI Pharmaceuticals Discloses Material De...
04/08/2024 21:03:35

On April 8, 2024, CASI Pharmaceuticals, announced that, with respect to the Company’s previously announced dispute with Juventa...

casi-pharmaceuticals-wins-emergency-relief-regarding-the-dispute-with-juventas-cell-therapy-ltd-prohibiting-juventas-from-commercializing-cnct19
CASI Pharmaceuticals Wins Emergency Relief...
04/08/2024 11:34:32

On April 8, 2024, CASI Pharmaceuticals, Inc., a Cayman Islands incorporated company  (“CASI” or the “Company”) announced that, ...

casi-pharmaceuticals-q4-eps-045-misses-024-estimate-sales-687m-miss-941m-estimate
CASI Pharmaceuticals Q4 EPS $(0.45) Misses...
03/28/2024 12:45:21

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate o...

recap-casi-pharmaceuticals-q4-earnings
Recap: CASI Pharmaceuticals Q4 Earnings
03/28/2024 12:20:12

casi-pharmaceuticals-fy2023-gaap-eps-202-misses-193-estimate-sales-3388m-miss-3642m-estimate
CASI Pharmaceuticals FY2023 GAAP EPS $(2.0...
03/28/2024 11:29:55

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(2.02) per share which missed the analyst consensus estimate o...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/08/2024 17:31:06

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/07/2024 13:06:06

casi-pharmaceuticals-blood-cancer-drug-shows-encouraging-clinical-efficacy-in-chinese-patients
CASI Pharmaceuticals Blood Cancer Drug Sho...
03/05/2024 17:16:54

CASI Pharmaceuticals and BioInvent share promising results for BI-1206 in treating relapsed/refractory indolent Non-Hodgkin'...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION